Charite University Hospital, Berlin – Germany
About Prof. Dr. Antonio Pezzutto
Prof. Dr. med. Antonio Pezzutto is a Senior Consultant Hematologist and Oncologist in Berlin with 42+ years of distinguished experience in leukaemia, lymphoma, stem cell transplantation, and tumour immunology. He directs the Department of Hematology, Oncology and Tumor Immunology at Charité Campus Benjamin Franklin and is co-author of leading immunology textbooks published by Thieme.
- 42+ years of distinguished experience in hematology, oncology, and tumour immunology
- Director — Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie, Charité Campus Benjamin Franklin (CBF)
- 265+ peer-reviewed publications with 7,023+ citations
- Concurrent role at Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin
- Co-author of “Taschenatlas der Immunologie” / “Color Atlas of Immunology” (Thieme)
Qualifications & Credentials
Medical Degrees
- Graduation — MBBS, University of Padova Medical School, Italy, 1972
- Post Graduation — Specialty Training in Internal Medicine and Hematology/Oncology, University of Heidelberg, Germany, 1983
Fellowships & Special Training
- Resident — University of Padova Medical School, Italy
- Resident — University of Heidelberg, Germany
- Specialty Training in Hematology, Oncology, and Tumour Immunology — University of Heidelberg
Certifications & Accreditations
- Berlin Medical Council Registration
- Specialist (Facharzt) Certification — Internal Medicine, Hematology, and Oncology, Germany
- Full Professor — Charité Berlin
Areas of Expertise
Major Conditions Treated
- Acute Leukaemias (AML, ALL)
- Chronic Leukaemias (CML, CLL)
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma (NHL)
- Peripheral T-Cell Lymphoma
- B-Cell Non-Hodgkin Lymphomas (with MYD88 Mutations)
- Multiple Myeloma
- Bleeding Disorders
- Blood Clots / Thrombotic Disorders
- Stem Cell Transplant Indications
- Solid Tumours (Medical Oncology)
Sub-specialties
- Stem Cell Transplantation: Specialist in autologous, allogenic, and umbilical cord blood stem cell transplantation — a leading hematologist specialist in Berlin for transplant-eligible blood cancer patients.
- Lymphoma & Tumour Immunology: Co-investigator on landmark trials (ECHELON-2, ACT-1) and research on MYD88 mutations in B-cell NHLs — among the best hematologist doctor in Germany for advanced lymphoma immunotherapy.
- Tumour Immunology & TCR Therapy: Past Medigene clinical TCR (T-cell receptor) study leader, contributing to next-generation immunotherapy.
Advanced Procedures & Treatments
- Autologous Stem Cell Transplantation
- Allogenic Stem Cell Transplantation
- Umbilical Cord Blood Transplantation
- Chemotherapy (Multi-Agent Regimens)
- Targeted Therapy (Tyrosine Kinase Inhibitors, Monoclonal Antibodies)
- Immunotherapy / Checkpoint Inhibitors
- T-Cell Receptor (TCR) Therapy
- Bone Marrow Aspiration & Biopsy
- Lymphoma Treatment Protocols (R-CHOP, ABVD, Brentuximab Vedotin)
- Leukaemia Induction & Consolidation Therapy
- Bleeding Disorder Management
List of Disease and Treatment for which Prof. Dr. Antonio Pezzutto can be consulted
Professional Experience
Current Affiliation
- Charité — Universitätsmedizin Berlin, Campus Benjamin Franklin (CBF), Germany — Director, Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie (Present)
- Charité Campus Virchow Klinikum, Augustenburger Platz 1, 13353 Berlin — Affiliated Faculty (Concurrent)
- Max-Delbrück-Centrum für Molekulare Medizin (MDC), Robert-Rössle-Straße 10, 13125 Berlin, Germany — Affiliated Researcher (Concurrent)
Past Affiliations
- Medigene AG — Clinical TCR (T-Cell Receptor) Study Leader (Past)
- University of Heidelberg, Germany — Specialty Training in Internal Medicine and Hematology/Oncology, 1983
- University of Heidelberg, Germany — Resident
- University of Padova Medical School, Italy — Resident and Medical Studies, completed 1972
Academic & Research Roles
- Full Professor — Charité Berlin
- Co-author — "Taschenatlas der Immunologie" with Burmester, Thieme
- Co-author — "Color Atlas of Immunology", Thieme
- Active researcher — MYD88 mutations in B-cell non-Hodgkin lymphomas
- Co-investigator — ECHELON-2 trial (Brentuximab Vedotin in peripheral T-cell lymphoma)
- Co-investigator — ACT-1 trial
- Past Medigene Clinical TCR Study Leader
Key Achievements
- 42+ years of distinguished experience in hematology, oncology, and tumour immunology
- 265+ peer-reviewed publications
- 7,023+ citations across the body of work
- Co-author of leading immunology textbooks (Thieme)
Awards & Recognitions
National & International Awards
- Full Professorship — Charité Berlin
- Co-authorship of internationally translated immunology textbooks (Thieme)
Professional Memberships
- German Society for Hematology and Medical Oncology (DGHO)
- European Society for Medical Oncology (ESMO)
- American Society of Hematology (ASH)
- American Society of Clinical Oncology (ASCO)
- European Hematology Association (EHA)
- Berlin Medical Council
Research & Publications
Published Papers (Selected)
- 265+ peer-reviewed scientific publications across hematology, oncology, and tumour immunology — accessible via PubMed.
- 7,023+ citations across the body of work.
- Burmester GR, Pezzutto A. Color Atlas of Immunology. Thieme.
- Burmester GR, Pezzutto A. Taschenatlas der Immunologie. Thieme.
- Co-investigator: ECHELON-2 Trial (Brentuximab Vedotin in peripheral T-cell lymphoma).
- Co-investigator: ACT-1 Trial.
Ongoing Research & Clinical Interests
- Stem cell transplantation outcomes
- MYD88 mutations in B-cell non-Hodgkin lymphomas
- Peripheral T-cell lymphoma (ECHELON-2)
- T-Cell Receptor (TCR) therapy and tumour immunology
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Hematology / Oncology Consultation | ₹15,000 – ₹35,000 | $180 – $420 |
| Autologous Stem Cell Transplant | ₹14,00,000 – ₹28,00,000 | $16,800 – $33,600 |
| Allogenic Stem Cell Transplant | ₹25,00,000 – ₹50,00,000 | $30,000 – $60,000 |
| Targeted Therapy (per month) | ₹2,00,000 – ₹6,50,000 | $2,400 – $7,800 |
| Immunotherapy / TCR Therapy | ₹3,50,000 – ₹10,00,000 | $4,200 – $12,000 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Antonio Pezzutto use in Hematologist treatment?
Prof. Dr. Antonio Pezzutto uses advanced hematology and oncology technologies including autologous, allogenic, and umbilical cord blood stem cell transplantation, modern targeted therapy, immunotherapy with checkpoint inhibitors, T-cell receptor (TCR) therapy, and advanced lymphoma protocols (R-CHOP, Brentuximab Vedotin) — supporting world-class blood cancer care.
2. What conditions does Dr. Antonio Pezzutto specialize in treating?
Prof. Dr. Antonio Pezzutto is a leading hematologist specialist in Berlin, Germany, treating acute and chronic leukaemias, Hodgkin and non-Hodgkin lymphomas, peripheral T-cell lymphoma, B-cell NHLs with MYD88 mutations, multiple myeloma, bleeding disorders, blood clots, and stem cell transplant indications — among the best hematologist doctor in Germany.
3. How do I book an appointment with Dr. Antonio Pezzutto?
Appointments with Prof. Dr. Antonio Pezzutto can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Antonio Pezzutto?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Prof. Dr. Antonio Pezzutto, including medical visa invitation letters, airport transfers, and local accommodation coordination in Berlin, Germany.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counseling, and pre-travel virtual consultations to review medical records before arrival in Germany.
6. Does Dr. Antonio Pezzutto offer second opinions for Hematologist cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients seeking expert review of leukaemia, lymphoma, multiple myeloma, or stem cell transplant cases from a leading Hematologist specialist in Berlin, Germany.
Charite University Hospital, Berlin - Germany
Blood Cancer
